Peter Ballard
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 13
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 13
- Co-authors
- Mireille Cantarini (4 shared papers)Kathryn Pickup (2 shared papers)Darren A.E. Cross (7 shared papers)James Yates (4 shared papers)James Chih‐Hsin Yang (2 shared papers)Pasi A. Jänne (3 shared papers)Peter Johnström (1 shared paper)Dong‐Wan Kim (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Pharmaceutical and Biomedical Analysis (5 papers)Molecular Cancer Therapeutics (3 papers)Pharmaceutical Research (3 papers)Xenobiotica (2 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Peter Ballard
46 papers receiving 1.4k citations
Peter Ballard's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 539
- Pulmonary and Respiratory Medicine 623
- Pharmacology 115
- Organic Chemistry 255
- Genetics 70
Countries citing papers authored by Peter Ballard
This map shows the geographic impact of Peter Ballard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ballard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ballard more than expected).
Fields of papers citing papers by Peter Ballard
This network shows the impact of papers produced by Peter Ballard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ballard. The network helps show where Peter Ballard may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ballard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity Hit paper breakdown → | 2016 | 544 |
| 2 | 2016 | 109 | |
| 3 | 2007 | 71 | |
| 4 | 2018 | 53 | |
| 5 | 2000 | 53 | |
| 6 | 2008 | 51 | |
| 7 | 2012 | 46 | |
| 8 | 2011 | 36 | |
| 9 | 2016 | 34 | |
| 10 | 2005 | 33 | |
| 11 | 2005 | 32 | |
| 12 | 2013 | 31 | |
| 13 | 2009 | 31 | |
| 14 | 2006 | 29 | |
| 15 | 2015 | 28 | |
| 16 | 2000 | 25 | |
| 17 | 2007 | 24 | |
| 18 | 2006 | 22 | |
| 19 | 2003 | 20 | |
| 20 | 2014 | 20 |
About Peter Ballard
Peter Ballard is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Lung Cancer Treatments and Mutations (13 papers), Quinazolinone synthesis and applications (9 papers), Pharmacogenetics and Drug Metabolism (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Analytical Chemistry and Chromatography (4 papers), COVID-19 epidemiological studies (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (539 citations), Pulmonary and Respiratory Medicine (623 citations), Pharmacology (115 citations), Organic Chemistry (255 citations) and Genetics (70 citations). Peter Ballard has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Mireille Cantarini, Kathryn Pickup, Darren A.E. Cross, James Yates, James Chih‐Hsin Yang, Pasi A. Jänne, Peter Johnström, Dong‐Wan Kim, Kenneth S. Thress and Jonas Malmquist. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmaceutical and Biomedical Analysis, Molecular Cancer Therapeutics, Pharmaceutical Research and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.